Skip to main content

Table 4 Overall response to induction treatment and concurrent radiochemotherapy

From: Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study

Response N. (%)
Induction Treatment   
Complete 9 (20.9)
Partial 23 (53.5)
Overall response 32 (74.4)
Stable Disease 10 (23.3)
Progression Disease 1 (2.3)
After concurrent radiochemotherapy   
Complete 22 (51.2)
Partial 20 (46.5)
Overall response 42 (97.7)
Stable Disease 1 (2.3)
Progression Disease 0 (0)